Technology developed at the University of Sussex helps hospitals make earlier and more accurate treatment decisions and survival assessments for patients with bowel cancer.
Nov 11, 2014
0
0
Patients who received post-operative radiation therapy (PORT), radiation therapy after surgery, lived an average of four months longer when compared to the patients who had the same disease site, tumor histology and treatment ...
Oct 30, 2014
0
0
Western-led research has discovered that timing, in combination with aggression, are possible keys to long-term survival for patients with limited metastatic lung cancer.
Oct 24, 2014
0
0
Two recently published studies by a research team at University Hospitals (UH) Case Medical Center Seidman Cancer Center have the potential to advance treatments for small cell lung cell cancer (SCLC). This aggressive form ...
Sep 25, 2014
0
1
There were only modest acute changes in cardiac biomarkers and electrocardiograms and there were no clinically significant cardiac events in patients with high-dose radiation exposure to the heart following thoracic radiation ...
Sep 24, 2014
0
0
Small RNA molecules, including microRNAs (miRNAs) and small interfering RNAs (siRNAs), offer tremendous potential as new therapeutic agents to inhibit cancer-cell growth. However, delivering these small RNAs to solid tumors ...
Aug 15, 2014
0
0
A 10-year population-based study shows that increased availability of better systemic chemo- and targeted-therapies for patients with advanced non-small cell lung cancer (NSCLC) coincides with increased usage of these therapies. ...
Jul 21, 2014
0
0
In 2012, about 8.2 million people died of cancer making the disease a major cause of death worldwide. According to the WHO World Cancer Report 2014, this figure is expected to rise within the next two decades. But new drugs ...
Jun 11, 2014
0
0
An old idea of retreating lung tumors with radiation is new again, especially with the technological advances seen in radiation oncology over the last decade.
May 8, 2014
0
0
A new era of lung cancer therapy is close to dawning, using drugs that can prevent tumour cells from evading the immune system, experts have said at the 4th European Lung Cancer Congress.
Mar 26, 2014
0
0
